Topical dorzolamide for treatment of cystoid macular edema in patients with choroideremia

Retina

Volumn 32, Issue 4, 2012, Pages 826-833

  Genead, Mohamed A ^a,b   McAnany, Jason J ^a   Fishman, Gerald A ^a,b  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^b Chicago Lighthouse for People Who Are Blind or Visually Impaired   (United States)

Author keywords

carbonic anhydrase inhibitor; choroideremia; cystoid macular edema; spectral domain OCT

Indexed keywords

DORZOLAMIDE;

ADULT; ARTICLE; CASE REPORT; CHOROIDEREMIA; CLINICAL FEATURE; DRUG EFFECT; DRUG EFFICACY; HUMAN; MALE; OUTCOME ASSESSMENT; RETINA MACULA CYSTOID EDEMA; TREATMENT OUTCOME;

CARBONIC ANHYDRASE INHIBITORS; CHOROIDEREMIA; CONTRAST SENSITIVITY; HUMANS; MACULAR EDEMA; MALE; MIDDLE AGED; SULFONAMIDES; THIOPHENES; TOMOGRAPHY, OPTICAL COHERENCE; TREATMENT OUTCOME; VISUAL ACUITY; VISUAL FIELD TESTS;

EID: 84859100042     PISSN: 0275004X     EISSN: 15392864     Source Type: Journal    
DOI: 10.1097/IAE.0b013e3182215ae9     Document Type: Article

References (29)

1. Andres DA, Seabra MC, Brown MS, et al. cDNA cloning of component A of Rab geranylgeranyl transferase and demonstration of its role as a Rab escort protein. Cell 1993;73:1091-1099. (Pubitemid 23180484)
2. Seabra MC. New insights into the pathogenesis of choroideremia: a tale of two REPs. Ophthalmic Genet 1996;17:43-46.
3. Roberts MF, Fishman GA, Roberts DK, et al. Retrospective, longitudinal, and cross sectional study of visual acuity impairment in choroideraemia. Br J Ophthalmol 2002;86:658-662. (Pubitemid 34627957)
4. Genead MA, Fishman GA. Cystic macular oedema onspectraldomain optical coherence tomography in choroideremia patients without cystic changes on fundus examination. Eye (Lond) 2011;25:84-90.
5. Hajali M, Fishman GA, Anderson RJ. The prevalence of cystoid macular oedema in retinitis pigmentosa patients determined by optical coherence tomography. Br J Ophthalmol 2008;92:1065-1068.
6. Walia S, Fishman GA, Hajali M. Prevalence of cystic macular lesions in patients with Usher II syndrome. Eye (Lond) 2009; 23:1206-1209.
7. Genead MA, Fishman GA, Walia S. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with X-linked retinoschisis. Arch Ophthalmol 2010; 128:190-197.
8. Sohn EH, Chen FK, Rubin GS, et al. Macular function assessed bymicroperimetry in patients with enhanced S-cone syndrome. Ophthalmology 2010;117:1199-1206.
9. Genead MA, Fishman GA, McAnany JJ. Efficacy of topical dorzolamide for treatment of cystic macular lesions in a patient with enhanced S-cone syndrome. Doc Ophthalmol 2010;121: 231-240.
10. Oliveira TL, Andrade RE, Muccioli C, et al. Cystoid macular edema ingyrate atrophy of the choroid and retina: a fluorescein angiography and optical coherence tomography evaluation. Am J Ophthalmol 2005;140:147-149. (Pubitemid 41008112)
11. Grover S, Apushkin MA, Fishman GA. Topical dorzolamide for the treatment of cystoid macular edema in patients with retinitis pigmentosa. Am J Ophthalmol 2006;141:850-858.
12. Genead MA, Fishman GA. Efficacy of sustained topical dorzolamide therapy for cystic macular lesions in patients with retinitis pigmentosa and Usher syndrome. Arch Ophthalmol 2010;128:1146-1150.
13. Bastos AL, Freitas Bde P, Villas Boas O, Ramiro AC. Use of topical dorzolamide for patients with X-linked juvenile retinoschisis: case report. Arq Bras Oftalmol 2008;71:286-290.
14. Iannaccone A, Fung KH, Eyestone ME, Stone EM. Treatment of adult-onset acute macular retinoschisis in enhanced s-cone syndrome with oral acetazolamide. Am J Ophthalmol 2009; 147:307-312.
15. Ko TH, Fujimoto JG, Schuman JS, et al. Comparison of ultrahigh- and standard-resolution optical coherence tomography for imaging macular pathology. Ophthalmology 2005;112: 1922.e1-e15
16. Scholda C,Wirtitsch M, Hermann B, et al. Ultrahigh resolution optical coherence tomography of macular holes. Retina 2006; 26:1034-1041. (Pubitemid 44973223)
17. Baba T, Yamamoto S, Arai M, et al. Correlation of visual recovery and presence of photoreceptor inner/outer segment junction in optical coherence images after successful macular hole repair. Retina 2008;28:453-458. (Pubitemid 351354947)
18. Midena E, Vujosevic S, Convento E, et al. Microperimetry and fundus autofluorescence in patients with early age-related macular degeneration. Br J Ophthalmol 2007;91:1499-1503. (Pubitemid 350044055)
19. Rohrschneider K, Bültmann S, Glück R, et al. Scanning laser ophthalmoscope fundus perimetry before and after laser photocoagulation for clinically significant diabetic macular edema. Am J Ophthalmol 2000;129:27-32. (Pubitemid 30026165)
20. Sunness JS, Applegate CA, Haselwood D, Rubin GS. Fixation patterns and reading rates in eyes with central scotomas from advanced atrophic age-related macular degeneration and Stargardt disease. Ophthalmology 1996;103:1458-1466. (Pubitemid 26353053)
21. Szlyk JP, Seiple W, Fishman GA, et al. Perceived and actual performance of daily tasks: relationship to visual function tests in patients with retinitis pigmentosa. Ophthalmology 2001; 108:65-75. (Pubitemid 32059538)
22. B. Mones J, Rubin G.Contrast sensitivity as an outcome measure in patients with subfoveal choroidal neovascularisation due to age-related macular degeneration. Eye 2005;19: 1142-1150.
23. Csaky KG, Richman EA, Ferris FL. 3rd Report from the NEI/ FDA Ophthalmic Clinical Trial Design and Endpoints Symposium. Invest Ophthalmol Vis Sci 2008;49:479-489.
24. Anastasakis A, McAnany JJ, Fishman GA, Seiple WH. Clinical value, normative retinal sensitivity values, and intrasession repeatability using a spectral-domain OCT/SLO microperimeter. Eye (Lond) 2011;25:245-251
25. Mäntyjärvi M, Laitinen T. Normal values for the Pelli-Robson contrast sensitivity test. J Cataract Refract Surg 2001;27: 261-266. (Pubitemid 32179506)
26. Quinn CJ. Cystoid macular edema. Optom Clin 1996;5:111-130.
27. Mura M, Sereda C, Jablonski MM, et al. Clinical and functional findings in choroideremia due to complete deletion of the CHM gene. Arch Ophthalmol 2007;125:1107-1113. (Pubitemid 47258042)
28. Jacobson SG, Cideciyan AV, Sumaroka A, et al. Remodeling of the human retina in choroideremia: rab escort protein 1 (REP- 1) mutations. Invest Ophthalmol Vis Sci 2006;47:4113-4120. (Pubitemid 46044330)
29. MacDonald IM, Russell L, Chan CC. Choroideremia: new findings from ocular pathology and review of recent literature. Surv Ophthalmol 2009;54:401-407.